title: Dopa-responsive dystonia with depigmentation of the substantia nigra and formation of Lewy bodies.
abstract: The patient, who died at 23 years of age, was first diagnosed when she was 12 year old as having a dopa-responsive dystonia with decreased concentrations of monoamine metabolites in the cerebrospinal fluid. Also the concentrations of other neurotransmitters including somatostatin, substance P and metenkefalin were lowered indicating a more widespread damage of the cerebral neurotransmitter systems. At autopsy the brain was essentially intact except for pronounced gliosis and extreme loss of melanotic nerve cells in the substantia nigra. Several remaining nerve cells showed the presence of Lewy bodies.
authors: Department of Neurology, University of Linköping, Sweden.
authors: J E
authors: JE
authors: Olsson
authors: U
authors: U
authors: Brunk
authors: B
authors: B
authors: Lindvall
authors: O
authors: O
authors: Eeg-Olofsson
mesh_terms: D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D002556:Cerebrospinal Fluid Proteins / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004298:Dopamine / Q000134:cerebrospinal fluid / Q000378:metabolism; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D016631:Lewy Bodies / Q000473:pathology*; D009479:Neuropeptides / Q000134:cerebrospinal fluid; D010858:Pigmentation; D013378:Substantia Nigra / Q000473:pathology*
chemical_list: D002556:Cerebrospinal Fluid Proteins; D009479:Neuropeptides; D001971:Bromocriptine; D004295:Dihydroxyphenylalanine; D004298:Dopamine